Medicines Law & Policy
LightNews LightNews
banner
medslawpolicy.bsky.social
Medicines Law & Policy
@medslawpolicy.bsky.social
50 followers 4 following 29 posts
Closing the knowledge gap on access to medicines and international law. Find our resources here: https://medicineslawandpolicy.org
Posts Replies Media Videos
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
@medslawpolicy.bsky.social 's annual (highly biased) 2025 year in review is here! Read what we thought were the most important goings on in global health law & policy here: medicineslawandpolicy.org/2025/12/wrap...
Fireworks over a lake
December 12, 2025 at 7:11 AM
medslawpolicy.bsky.social
Wrapping up 2025: A tumultuous year for global public health law & policy
The end of 2025, a tumultuous year for global public health, is here, and it’s time for the usually highly biased Medicines Law & Policy report of the key events...
medicineslawandpolicy.org
December 11, 2025 at 12:21 PM
medslawpolicy.bsky.social
Wrapping up 2019 - Noteworthy Medicines Law and Policy Events
2019 had its share of noteworthy medicines law and policy events. It was also a year that saw eye-popping new levels of pharmaceutical pricing. And governments in response began to...
medicineslawandpolicy.org
December 11, 2025 at 11:58 AM
medslawpolicy.bsky.social
Wrapping up 2023 with some noteworthy medicines, law and policy developments
Welcome to our 2023 end-of-the-year blog, our annual and highly-biased run-through of notable access to medicines events of the year that is about to end.  As we close the year,...
medicineslawandpolicy.org
December 11, 2025 at 11:44 AM
medslawpolicy.bsky.social
Wrapping up 2024: Noteworthy events in medicines law and policy around the globe
Welcome to Medicines Law & Policy’s  end of the year blog, our highly biased annual overview of memorable medicines law and policy events. January At the January World Trade Organization’s...
medicineslawandpolicy.org
December 11, 2025 at 11:44 AM
medslawpolicy.bsky.social
2018 Round-up of Noteworthy Medicines Law and Policy Events
We are reaching the end of 2018: Time for our end-of-the-year roundup of some significant developments in medicines law and policy. January The Chilean parliament started 2018, on 3 January,...
medicineslawandpolicy.org
December 11, 2025 at 11:44 AM
medslawpolicy.bsky.social
Wrapping up 2021 - some noteworthy medicines law and policy events
Welcome to the annual end of the year blog, our highly biased overview of noteworthy events in the field of medicines law and policy. It will not come as a...
medicineslawandpolicy.org
December 11, 2025 at 11:44 AM
medslawpolicy.bsky.social
Wrapping up 2022 with some noteworthy medicines, law and policy events
Welcome to our annual, highly biased, overview of noteworthy events in the field of medicines law and policy. Also in 2022, Covid-19 remained a central concern in global health and...
medicineslawandpolicy.org
December 11, 2025 at 11:44 AM
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
“Transitioning to self-reliance sounds good but what is happening today is not a transition. It is a shock to the system of which the most vulnerable will carry the brunt”, says @ellenthoen.bsky.social in a new @thelancet.com here:
Global health aid cuts: WHO urges urgent action to protect vulnerable populations
With drastic reductions in health aid threatening essential services and millions of lives, WHO issues new guidance for countries to safeguard health budgets, limit out-of-pocket payments, and mobilis...
www.thelancet.com
November 26, 2025 at 9:43 AM
medslawpolicy.bsky.social
The Role of Activism in Shaping Law and Policies that Support Access to Medicines
This post is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans Frontières, and the Consumer Project...
medicineslawandpolicy.org
November 11, 2025 at 12:25 PM
medslawpolicy.bsky.social
Affordability, binding commitments to technology sharing, and transparency key in Pathogen Access and Benefit Sharing
We appreciate the opportunity to offer comments on the draft PABS annex text . Some preliminary comments: Affordability of Access: The current draft mentions "providing access to products" and "rapid...
medicineslawandpolicy.org
November 3, 2025 at 2:10 PM
medslawpolicy.bsky.social
Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year - expanding access and prolonging lives
Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope to parents unable to afford the...
medicineslawandpolicy.org
October 24, 2025 at 4:36 PM
medslawpolicy.bsky.social
Read ML&P's statement, delivered by @ellenthoen.bsky.social , at the opening session of the Intergovernmental Working Group on the Pandemic Agreement here: medicineslawandpolicy.org/2025/09/the-...
The IGWG process offers an opportunity to fulfil the equity objectives of the Pandemic Agreement | Medicines Law & Policy
medicineslawandpolicy.org
September 15, 2025 at 7:34 AM
medslawpolicy.bsky.social
The IGWG process offers an opportunity to fulfil the equity objectives of the Pandemic Agreement
Co-Chairs,  Thank you for the opportunity to make a brief intervention. Both the sharing of pathogens and the sharing of the benefits, including products and knowledge, resulting from this should...
medicineslawandpolicy.org
September 15, 2025 at 7:16 AM
medslawpolicy.bsky.social
WHO Members meet to finalise the Pathogen Access and Benefit Sharing Instrument
In May 2025, the WHO member states adopted the Pandemic Agreement, but they left the work to establish an instrument for Pathogen Access and Benefit Sharing (PABS) for a later...
medicineslawandpolicy.org
September 10, 2025 at 6:00 AM
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
Treatment for cystic fibrosis added to Essential Medicines List by the World Health Organization: A victory for campaigners, though prices still ‘toxic’: Check out our new block on the Essential Medicines List: medicineslawandpolicy.org/2025/09/trea...
September 5, 2025 at 4:50 PM
medslawpolicy.bsky.social
Treatment for cystic fibrosis treatments added to Essential Medicines by the World Health Organization: A victory for campaigners, though prices still ‘toxic’
The World Health Organization today announced it has added the cystic fibrosis combination treatment elexacaftor + tezacaftor + ivacaftor (brand name Trikafta) to its Model Lists of Essential Medicines (EML)...
medicineslawandpolicy.org
September 5, 2025 at 4:15 PM
medslawpolicy.bsky.social
US Authorisation of Non-Voluntary Use of Patents frequently used for health technologies
During the Covid-19 pandemic, the United States prioritised the rapid development of products needed to combat the health crisis.  Rapid product development was pursued through the use of a statute...
medicineslawandpolicy.org
September 4, 2025 at 11:29 AM
medslawpolicy.bsky.social
FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending HIV
On 18th June 2015, the US Food and Drug Administration (FDA) approved the use of long-acting antiretroviral medicine lenacapavir (LEN-LA), for the prevention of HIV, also known as pre-exposure prophylaxis...
medicineslawandpolicy.org
June 19, 2025 at 9:43 AM
medslawpolicy.bsky.social
Transfer of technology and know-how for the production of pandemic-related health products in the WHO Pandemic Agreement: the proverbial half glass 
A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot During the COVID-19 pandemic, the delayed...
medicineslawandpolicy.org
June 16, 2025 at 6:00 AM
medslawpolicy.bsky.social
The People vs. AbbVie
Today, 9 May 2025, is an important day in court for the Dutch Pharmaceutical Accountability Foundation (PAF). In February 2023, PAF started a court case against AbbVie, over AbbVie’s excessive...
medicineslawandpolicy.org
May 9, 2025 at 2:01 AM
medslawpolicy.bsky.social
The Pandemic Agreement is here
In December 2021, the member states of the World Health Organization decided “to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response”,...
medicineslawandpolicy.org
April 16, 2025 at 9:49 AM
medslawpolicy.bsky.social
Pharmaceutical patents and data exclusivity in an age of AI-driven drug discovery and development
This is an excerpt from a longer report on AI, medicines development and the patent system. Download the full report here (or by clicking on the image at left). Rapid...
medicineslawandpolicy.org
April 14, 2025 at 7:15 AM
medslawpolicy.bsky.social
Expanding local production is essential for pandemic preparedness. It requires, however, transfer of technology.
Madam co-chairs, delegates,  This very week, from 7 to 9 April the 3rd World Local Production Forum is taking place in Abu Dhabi. Actions towards expanding local production of medical...
medicineslawandpolicy.org
April 9, 2025 at 7:32 AM
medslawpolicy.bsky.social
Respect for intellectual property law includes respecting the flexibilities it contains to protect the public interest: ML&P’s opening statement to the INB
Thank you for the opportunity to speak. And for the latest draft of the pandemic agreementshared with us on 26 March. In particular, we were pleased to see in the...
medicineslawandpolicy.org
April 8, 2025 at 6:43 AM